Can we all be happier with a more streamlined prior authorization process? This NEHI white paper provides context and recommendations.

What we’re thinking about at NEHI: two-way communication between patient communities and health care payers when new, novel and very challenging therapies are approved by the FDA.

UPDATE September 28, 2021: In the interest of public health during the ongoing COVID-19 pandemic, NEHI has made the decision to postpone our Innovators in Health Awards until further notice.

NEHI convened corporate and community leaders from around the country to help define a roadmap to collaborations that advance equitable health care and health outcomes for Americans who suffer from longstanding disparities.